Terasaki Institute for Biomedical Innovation Announces Inaugural Leadership Board
News provided by
Share this article
Share this article
LOS ANGELES, April 27, 2021 /PRNewswire/ The Terasaki Institute for Biomedical Innovation announces the establishment of the inaugural Leadership Board. This board brings together individuals passionate about research and technology to enhance and create practical solutions for patient health and wellness and provides vital opportunity to support the growth of the Institute. This board includes distinguished individuals who will leverage their expertise to provide strategic guidance on innovation, research areas, promote key initiatives, and support the mission and vision of the Institute.
Joining the newly established Leadership Board is Sultana Afdhal, George Ayoub, Alex Goldberg, Stephen Ibaraki, Frank Litvack, Asad M. Madni, David Nazarian, and Douglas A. Wilson.
XSEED SuperTeacher Now Available In App Stores For Free Trial Download - Teach Any Child Anytime And Anywhere
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Mister Rogers s blueprint for Joe Biden
thehill.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehill.com Daily Mail and Mail on Sunday newspapers.
Monday 19 April 2021
Today, BMJ Innovations announced a strategic partnership with The World Innovation Summit for Health (WISH), Qatar Foundation’s global health initiative. The partnership will help advance their shared vision of a healthier world by disseminating evidence-based and best-practice innovation.
Since first published in 2015, BMJ Innovations (the specialist peer-reviewed online journal from BMJ) has focused on emerging digital health, medical devices, process and system innovations. This new partnership with WISH will increase the publication of the best available original research, provide greater global access to evidence-based innovation practice, and support the development of themed issues on topics where new innovations can make an impact.